Nathan, D. M. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 37, 9–16 (2014).

Article  CAS  PubMed  Google Scholar 

Thabit, H. et al. Home use of an artificial beta cell in type 1 diabetes. N. Engl. J. Med. 373, 2129–2140 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keenan, H. A. et al. Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 59, 2846–2853 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shapiro, A. M. J. et al. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355, 1318–1330 (2006).

Article  CAS  PubMed  Google Scholar 

Reichman, T. W. et al. Stem cell-derived, fully differentiated islets for type 1 diabetes. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2506549 (2025).

Article  PubMed  Google Scholar 

Wang, S. et al. Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell 187, 6152–6164 (2024).

Article  CAS  PubMed  Google Scholar 

Herold, K. C. et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N. Engl. J. Med. 381, 603–613 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ziegler, A. G. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309, 2473–2479 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar